Almere, The Netherlands
March 24, 2017
ASM International N.V. (Euronext Amsterdam: ASM) today announces that Eminence Capital LP has requested the Company to place the following discussion item on the agenda for the coming Annual General Meeting of Shareholders (AGM) to be held on May 22, 2017: "Discussion of the policy of the Management Board and the Supervisory Board in relation to ASMI's shareholding in ASM Pacific Technology Ltd. in 2016 and thereafter and the risks and benefits of a full divestiture of it."
Pursuant to the articles of association of ASMI and Dutch law any shareholder holding at least 3% in ASMI's capital may request the inclusion of items in the agenda of the AGM at least 60 days in advance of the meeting. With respect to the request of Eminence Capital these conditions are satisfied and hence ASMI will include this item on the AGM agenda as requested.
ASMI views long-term value creation as very important. Regularly the Management Board reviews its strategy and, as part of that, the position it holds in ASMPT. The Management Board remains of the opinion that, at this moment, a significant stake in ASMPT is of strategic value for the Company.
About ASM International
ASM International NV, headquartered in Almere, the Netherlands, its subsidiaries and participations design and manufacture equipment and materials used to produce semiconductor devices. ASM International, its subsidiaries and participations provide production solutions for wafer processing (Front-end segment) as well as for assembly & packaging and surface mount technology (Back-end segment) through facilities in the United States, Europe, Japan and Asia. ASM International's common stock trades on the Euronext Amsterdam Stock Exchange (symbol ASM). For more information, visit ASMI's website at www.asm.com.
Cautionary Note Regarding Forward-Looking Statements: All matters discussed in this press release, except for any historical data, are forward-looking statements. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. These include, but are not limited to, economic conditions and trends in the semiconductor industry generally and the timing of the industry cycles specifically, currency fluctuations, corporate transactions, financing and liquidity matters, the success of restructurings, the timing of significant orders, market acceptance of new products, competitive factors, litigation involving intellectual property, shareholders or other issues, commercial and economic disruption due to natural disasters, terrorist activity, armed conflict or political instability, epidemics and other risks indicated in the Company's reports and financial statements. The Company assumes no obligation nor intends to update or revise any forward-looking statements to reflect future developments or circumstances.
CONTACT
Investor contact:
Victor Bareño
T: +31 88 100 8500
Media contact:
Ian Bickerton
T: +31 625 018 512
Attachments:
http://www.globenewswire.com/NewsRoom/AttachmentNg/8c36f538-b8f4-4de0-b2fc-4f4a8b6fd7da


Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Instagram Outage Disrupts Thousands of U.S. Users
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 



